Refresh

DR.REDDY'S LABORATORIES LTD. - Dr Reddy's Laboratories Limited and AstraZeneca Pharma India Limited entered into a distribution agreement for saxagliptin and its fixed dose combination with metformin, in Type 2 Diabetes


Download
29 May 2015
Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated May 29, 2015 titled "Dr Reddy's Laboratories Limited and AstraZeneca Pharma India Limited entered into a distribution agreement for saxagliptin and its fixed dose combination with metformin, in Type 2 Diabetes".

Source: BSE India

View all announcements for DR.REDDY'S LABORATORIES LTD.
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com